[Brazilian Consensus on Chagas Disease, 2015]
- PMID: 27869914
- DOI: 10.5123/S1679-49742016000500002
[Brazilian Consensus on Chagas Disease, 2015]
Abstract
Chagas disease is a neglected chronic condition that presents high morbidity and mortality burden, with considerable psychological, social, and economic impact. The disease represents a significant public health issue in Brazil, with different regional patterns. This document presents the evidence that resulted in the Brazilian Consensus on Chagas Disease. The objective was to review and standardize strategies for diagnosis, treatment, prevention, and control of Chagas disease in the country, based on the available scientific evidence. The consensus is based on collaboration and contribution of renowned Brazilian experts with vast knowledge and experience on various aspects of the disease. It is the result of close collaboration between the Brazilian Society of Tropical Medicine and the Ministry of Health. This document shall strengthen the development of integrated control measures against Chagas disease in the country, focusing on epidemiology, management, comprehensive care (including families and communities), communication, information, education, and research.
Similar articles
-
Chagas disease in non-endemic settings.BMJ. 2021 Apr 9;373:n901. doi: 10.1136/bmj.n901. BMJ. 2021. PMID: 33837041 No abstract available.
-
COVID-19: Implications for People with Chagas Disease.Glob Heart. 2020 Oct 13;15(1):69. doi: 10.5334/gh.891. Glob Heart. 2020. PMID: 33150134 Free PMC article. Review.
-
WHF IASC Roadmap on Chagas Disease.Glob Heart. 2020 Mar 30;15(1):26. doi: 10.5334/gh.484. Glob Heart. 2020. PMID: 32489799 Free PMC article. Review.
-
Mortality Trends for Neglected Tropical Diseases in the State of Sergipe, Brazil, 1980-2013.Infect Dis Poverty. 2017 Feb 8;6(1):20. doi: 10.1186/s40249-016-0232-8. Infect Dis Poverty. 2017. PMID: 28173858 Free PMC article.
-
2 nd Brazilian Consensus on Chagas Disease, 2015.Rev Soc Bras Med Trop. 2016 Dec;49Suppl 1(Suppl 1):3-60. doi: 10.1590/0037-8682-0505-2016. Rev Soc Bras Med Trop. 2016. PMID: 27982292
Cited by
-
Survival analysis of Chagas disease patients, beneficiaries of social security and social assistance in Brazil, 1942-2016.Rev Bras Epidemiol. 2024 May 17;27:e240020. doi: 10.1590/1980-549720240020. eCollection 2024. Rev Bras Epidemiol. 2024. PMID: 38775617 Free PMC article.
-
Improving in vitro screening compounds anti-Trypanosoma cruzi by GFP-expressing parasites.Mem Inst Oswaldo Cruz. 2024 May 6;119:e230223. doi: 10.1590/0074-02760230223. eCollection 2024. Mem Inst Oswaldo Cruz. 2024. PMID: 38716979 Free PMC article.
-
New insights into Trypanosoma cruzi genetic diversity, and its influence on parasite biology and clinical outcomes.Front Immunol. 2024 Apr 9;15:1342431. doi: 10.3389/fimmu.2024.1342431. eCollection 2024. Front Immunol. 2024. PMID: 38655255 Free PMC article. Review.
-
Clinical trials for Chagas disease: etiological and pathophysiological treatment.Front Microbiol. 2023 Dec 15;14:1295017. doi: 10.3389/fmicb.2023.1295017. eCollection 2023. Front Microbiol. 2023. PMID: 38188583 Free PMC article. Review.
-
Chronic Chagas Cardiomyopathy in the Brazilian Amazon region: clinical characteristics and regional distinctiveness.Front Public Health. 2023 Nov 27;11:1284639. doi: 10.3389/fpubh.2023.1284639. eCollection 2023. Front Public Health. 2023. PMID: 38089032 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical